Prospective evaluation of mpMRI-derived nomograms for detecting prostate cancer in PI-RADS v2.1 upgraded and non-upgraded lesions

BackgroundLimited data exist on the performance of Prostate Imaging Reporting and Data System (PI-RADS) v2.1 upgraded and non-upgraded lesions, both alone and in combined with multiparametric MRI (mpMRI) features, for prostate cancer detection.ObjectiveTo evaluate the rates of prostate cancer (PCa)...

Full description

Saved in:
Bibliographic Details
Main Authors: Ying Yi, Hang Wang, Dongliang Cheng, Zhifeng Xu, Xianhai Zhang, Chun Luo, Hai Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1510049/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849696822692413440
author Ying Yi
Hang Wang
Dongliang Cheng
Zhifeng Xu
Xianhai Zhang
Chun Luo
Hai Zhao
author_facet Ying Yi
Hang Wang
Dongliang Cheng
Zhifeng Xu
Xianhai Zhang
Chun Luo
Hai Zhao
author_sort Ying Yi
collection DOAJ
description BackgroundLimited data exist on the performance of Prostate Imaging Reporting and Data System (PI-RADS) v2.1 upgraded and non-upgraded lesions, both alone and in combined with multiparametric MRI (mpMRI) features, for prostate cancer detection.ObjectiveTo evaluate the rates of prostate cancer (PCa) and clinically significant prostate cancer(csPCa) rates in PI-RADS v2.1 upgraded and non-upgraded lesions, and to identify mpMRI features that improve detection accuracy.MethodsThis study included men who underwent mpMRI and ultrasound-guided (US-guided) biopsy from March 2023 to April 2024. MRI scans were prospectively evaluated according to PI-RADS v2.1. MpMRI features were extracted from lesion contours, including three-dimensional maximum diameter, lesion volume, sphericity, surface-to-volume ratio (SVR), T2-weighted imaging signal intensity(T2WI SI), diffusion-weighted imaging(DWI) SI, T1, T2, proton density (PD), apparent diffusion coefficient (ADC), and dynamic contrast-enhanced (DCE) MRI-derived time intensity curve (TIC). Univariable and multivariable logistic regression analyses were performed to identify features associated with PCa and csPCa in different prostate zones (transition zone and peripheral zone).ResultsA total of 94 patients(mean age, 65.7 years) with 234 lesions were included. Significant differences were observed between upgraded and non-upgraded PI-RADS 4 lesions(p < 0.05) in the peripheral zone (PZ), whereas no significant differences were found in the transition zone (TZ). Risk factors for csPCa in the TZ included lesion diameter, TIC type III, capsule, T1 and PD values. For csPCa in the PZ, T1, SVR, DWI SI, and ADC values were identified as important risk factors. ROC analysis demonstrated high diagnostic accuracy for csPCa detection, with AUCs of 0.93 (TZ) and 0.96 (PZ).ConclusionPI-RADS v2.1 upgrading rules improve cancer detection in the TZ, but upgrading PI-RADS category 3 lesions in the PZ may lead to unnecessary biopsies. MpMRI-based nomograms enhance predictive accuracy for both PCa and csPCa.
format Article
id doaj-art-d14af3645feb4236a960045f37b834f7
institution DOAJ
issn 2234-943X
language English
publishDate 2025-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj-art-d14af3645feb4236a960045f37b834f72025-08-20T03:19:20ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2025-06-011510.3389/fonc.2025.15100491510049Prospective evaluation of mpMRI-derived nomograms for detecting prostate cancer in PI-RADS v2.1 upgraded and non-upgraded lesionsYing YiHang WangDongliang ChengZhifeng XuXianhai ZhangChun LuoHai ZhaoBackgroundLimited data exist on the performance of Prostate Imaging Reporting and Data System (PI-RADS) v2.1 upgraded and non-upgraded lesions, both alone and in combined with multiparametric MRI (mpMRI) features, for prostate cancer detection.ObjectiveTo evaluate the rates of prostate cancer (PCa) and clinically significant prostate cancer(csPCa) rates in PI-RADS v2.1 upgraded and non-upgraded lesions, and to identify mpMRI features that improve detection accuracy.MethodsThis study included men who underwent mpMRI and ultrasound-guided (US-guided) biopsy from March 2023 to April 2024. MRI scans were prospectively evaluated according to PI-RADS v2.1. MpMRI features were extracted from lesion contours, including three-dimensional maximum diameter, lesion volume, sphericity, surface-to-volume ratio (SVR), T2-weighted imaging signal intensity(T2WI SI), diffusion-weighted imaging(DWI) SI, T1, T2, proton density (PD), apparent diffusion coefficient (ADC), and dynamic contrast-enhanced (DCE) MRI-derived time intensity curve (TIC). Univariable and multivariable logistic regression analyses were performed to identify features associated with PCa and csPCa in different prostate zones (transition zone and peripheral zone).ResultsA total of 94 patients(mean age, 65.7 years) with 234 lesions were included. Significant differences were observed between upgraded and non-upgraded PI-RADS 4 lesions(p < 0.05) in the peripheral zone (PZ), whereas no significant differences were found in the transition zone (TZ). Risk factors for csPCa in the TZ included lesion diameter, TIC type III, capsule, T1 and PD values. For csPCa in the PZ, T1, SVR, DWI SI, and ADC values were identified as important risk factors. ROC analysis demonstrated high diagnostic accuracy for csPCa detection, with AUCs of 0.93 (TZ) and 0.96 (PZ).ConclusionPI-RADS v2.1 upgrading rules improve cancer detection in the TZ, but upgrading PI-RADS category 3 lesions in the PZ may lead to unnecessary biopsies. MpMRI-based nomograms enhance predictive accuracy for both PCa and csPCa.https://www.frontiersin.org/articles/10.3389/fonc.2025.1510049/fullprostate cancermultiparametric magnetic resonance imagingnomogrampredictive modelsynthetic MRIPI-RADS v2.1
spellingShingle Ying Yi
Hang Wang
Dongliang Cheng
Zhifeng Xu
Xianhai Zhang
Chun Luo
Hai Zhao
Prospective evaluation of mpMRI-derived nomograms for detecting prostate cancer in PI-RADS v2.1 upgraded and non-upgraded lesions
Frontiers in Oncology
prostate cancer
multiparametric magnetic resonance imaging
nomogram
predictive model
synthetic MRI
PI-RADS v2.1
title Prospective evaluation of mpMRI-derived nomograms for detecting prostate cancer in PI-RADS v2.1 upgraded and non-upgraded lesions
title_full Prospective evaluation of mpMRI-derived nomograms for detecting prostate cancer in PI-RADS v2.1 upgraded and non-upgraded lesions
title_fullStr Prospective evaluation of mpMRI-derived nomograms for detecting prostate cancer in PI-RADS v2.1 upgraded and non-upgraded lesions
title_full_unstemmed Prospective evaluation of mpMRI-derived nomograms for detecting prostate cancer in PI-RADS v2.1 upgraded and non-upgraded lesions
title_short Prospective evaluation of mpMRI-derived nomograms for detecting prostate cancer in PI-RADS v2.1 upgraded and non-upgraded lesions
title_sort prospective evaluation of mpmri derived nomograms for detecting prostate cancer in pi rads v2 1 upgraded and non upgraded lesions
topic prostate cancer
multiparametric magnetic resonance imaging
nomogram
predictive model
synthetic MRI
PI-RADS v2.1
url https://www.frontiersin.org/articles/10.3389/fonc.2025.1510049/full
work_keys_str_mv AT yingyi prospectiveevaluationofmpmriderivednomogramsfordetectingprostatecancerinpiradsv21upgradedandnonupgradedlesions
AT hangwang prospectiveevaluationofmpmriderivednomogramsfordetectingprostatecancerinpiradsv21upgradedandnonupgradedlesions
AT dongliangcheng prospectiveevaluationofmpmriderivednomogramsfordetectingprostatecancerinpiradsv21upgradedandnonupgradedlesions
AT zhifengxu prospectiveevaluationofmpmriderivednomogramsfordetectingprostatecancerinpiradsv21upgradedandnonupgradedlesions
AT xianhaizhang prospectiveevaluationofmpmriderivednomogramsfordetectingprostatecancerinpiradsv21upgradedandnonupgradedlesions
AT chunluo prospectiveevaluationofmpmriderivednomogramsfordetectingprostatecancerinpiradsv21upgradedandnonupgradedlesions
AT haizhao prospectiveevaluationofmpmriderivednomogramsfordetectingprostatecancerinpiradsv21upgradedandnonupgradedlesions